The global substance abuse treatment market comprises of therapeutic drugs, assessment tools, and counseling services meant for treating substance use disorders, including alcohol, tobacco, and drug addiction. The treatment market covers opiate addiction treatment, non-opiate treatment drugs, and behavioral therapies to treat substance abuse effectively and provide long-term recovery. The rising incidence of substance abuse disorders due to increased social acceptance of recreational drug use and lack of awareness about addiction has fueled the need for effective treatment options.
The Global substance abuse treatment Market Demand is estimated to be valued at US$ 11.8 BN in 2024 and is expected to exhibit a CAGR of 8.5% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the global substance abuse treatment are Indivior PLC, Pfizer, Inc., Johnson & Johnson Inc., Alkermes., Mallinckrodt Pharmaceuticals, Teva Pharmaceuticals, Inc., Par Pharmaceutical, Inc., USWM, LLC, Valeant Pharmaceuticals, Greenyard Pharmaceutical Ltd. Cipla Health Limited. Perrigo, Haleon Group of Companies, Ventus Medical, Glenmark and other prominent players.
The rising awareness about substance use disorder and associated health risks has opened up huge opportunities for substance abuse treatment providers. Widespread promotional campaigns by health organizations and government bodies on signs of addiction and available treatment options are encouraging more people to seek professional help, thereby amplifying the market potential.
Key players are actively expanding their geographical footprint through collaborations, mergers, and acquisition activities to establish a global presence. For instance, in 2025, Alkermes acquired RB Health to penetrate the European substance abuse treatment market. Rising accessibility to treatment worldwide due to the efforts of leading providers will further fuel the market growth.
Market drivers: Growing social acceptance and easy availability of drugs have increased substance abuse significantly among the young population fueling the need for advanced treatment. Rising awareness about adverse health effects of addiction and government initiatives to promote treatment seeking behavior are also driving the market growth.
Market restraints: Low treatment seeking rates due to stigma surrounding addiction discourage people from opting for professional help. Lack of health insurance coverage for substance abuse treatment in many countries increases the financial burden on patients, limiting market growth. High costs of novel therapeutics and relapse during recovery are major challenges faced by the market.
Segment Analysis
The Global Substance Abuse Treatment Market is dominated by the outpatient treatment sub-segment owing to ease of accessibility of such facilities as compared to inpatient rehab centers. Outpatient rehab centers allow patients to live at home and visit the facility only for specific counseling and therapy sessions. This flexibility helps in encouraging more people to seek timely medical help without disrupting their daily lives and work. Other prominent sub-segments include inpatient treatment, residential treatment, and counselling and therapy.
Regional Analysis
North America dominates the global market due to rising awareness initiatives by public as well as private institutions. The region is projected to remain the largest market during the forecast period. Growing opioid addiction, increasing focus on advanced treatment therapies, and favourable reimbursement policies facilitate the market growth in North America. Europe represents the second largest market worldwide on account rapid growth in the number of people seeking treatment for substance abuse and rising expenditure on healthcare. Asia Pacific market is propelled by growing substance abuse issues in countries like China, India, Australia, and Japan. This has encouraged governments as well as private entities to boost addiction treatment programs across the region.
Get more insights on this topic: Global Substance Abuse Treatment Market
Comments
0 comment